LANXESS Valuation
Is LX9B undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of LX9B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: LX9B (€4.56) is trading below our estimate of fair value (€10.71)
Significantly Below Fair Value: LX9B is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for LX9B?
Key metric: As LX9B is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is LX9B's PS Ratio? | |
|---|---|
| PS Ratio | 0.3x |
| Sales | €6.32b |
| Market Cap | €2.05b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.7x |
| Enterprise Value/EBITDA | 9.3x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does LX9B's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.5x | ||
BAS BASF | 0.6x | 4.4% | €37.5b |
SDF K+S | 0.5x | 0.4% | €2.0b |
WCH Wacker Chemie | 0.6x | 5.2% | €3.5b |
TKA thyssenkrupp | 0.07x | 1.1% | €2.4b |
LX9B LANXESS | 0.3x | 2.8% | €2.0b |
Price-To-Sales vs Peers: LX9B is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.5x).
Price to Sales Ratio vs Industry
How does LX9B's PS Ratio compare vs other companies in the European Chemicals Industry?
| 27 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 27 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: LX9B is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Chemicals industry average (1x).
Price to Sales Ratio vs Fair Ratio
What is LX9B's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.3x |
| Fair PS Ratio | 0.4x |
Price-To-Sales vs Fair Ratio: LX9B is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Central Asia Metals
UK£282.2m
Operates as a base metals producer.
9C3
UK£1.90
7D
1.1%
1Y
0.5%
Minerals Technologies
US$2.6b
Develops, produces, and markets various mineral, mineral-based, and related systems and services.
MNK
US$74.50
7D
1.4%
1Y
33.0%
Cabka
€60.3m
Manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally.
7GW
€2.38
7D
-7.8%
1Y
-61.1%